Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Retatrutide Status Retatrutide remains in Phase 3 clinical trials with FDA approval projected for late 2026 to early 2027
GLP-2 binds the GLP-2 receptor, which sits almost entirely in the gut itself
Commonly, initial treatment may involve weekly injections for a few weeks, followed by monthly maintenance doses as needed
Bonaca's team found that patients' improved walking ability didn't strongly correlate with how much weight they lost
By removing friction points like long wait times, high costs, and stigma, virtual platforms make it easier for patients to get started
US$ 21.95
US$ 23.42
US$ 21.69
US$ 29.70
US$ 26.72
